Results 291 to 300 of about 69,874,824 (396)

Chemical analysis of bacterial polysaccharides

, 1956
Teiichi SASAKI
openalex   +2 more sources

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Propofol Versus Methohexital in Electroconvulsive Therapy: Impact on Treatment Efficacy and Adverse Effects. A Systematic Literature Review and Meta-Analysis. [PDF]

Acta Anaesthesiol Scand
Huoponen SH, Sisa K, Saari T, Taittonen M, Ahlmén-Laiho U.   +4 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Pan-cancer analysis and experimental validation revealed the prognostic role of ZNF83 in renal and lung cancer cohorts. [PDF]

Discov Oncol
Wu P, Lin Y, Dai F, Wang H, Wen H, Xu Z, Sun G, Lyu Z.   +7 more
europepmc   +1 more source

An Experimental Mass Spectrometer for the Isotopic Analysis of Uranium

, 1959
Nozomu Morito, Junichi Okamoto, Yasuo Nakajima, Hitoshi Tsuyama, Itiro Omura, T. Noda, Wataru Noguchi   +6 more
openalex   +2 more sources

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Falling and Landing Framework (FLF): A Consensus on a Novel Falling and Landing Video Analysis Framework for Use Across Rugby Codes. [PDF]

Eur J Sport Sci
Petrie FJ, Woodward JS, McLeod S, West SW, Salmon D, Gardner AJ, Shill IJ, Romanchuk J, Dane K, Kitchin M, Jones B, Mackintosh KA, Starbuck C, Hendricks S, Philips G, Jones S, Tierney G, McNarry MA.   +17 more
europepmc   +1 more source

Pentane-Pentene Mixture Analysis by Mass Spectrometer and GLPC.

, 1958
Tetsuo Kitamura, Koji Katsuura, Koichi Arimoto   +2 more
openalex   +2 more sources

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source